Related Experiment Videos
[Granulomatous hepatitis successfully treated with ursodeoxycholic acid]
Eszter Németh1, Elemér Bugovics, Gabriella Lengyel
1Semmelweis Egyetem, Altalános Orvostudományi Kar, II. Belgyógyászati Klinika. eszternemeth@freemail.hu
Orvosi Hetilap
|September 20, 2006
Summary
Granulomatous hepatitis, often systemic, can present as a primary liver issue. This case highlights a rare presentation of primary sclerosing cholangitis diagnosed via liver biopsy and confirmed by subsequent ulcerative colitis.
Area of Science:
- Hepatology
- Gastroenterology
- Immunology
Background:
- Granulomatous hepatitis involves hepatic inflammation from granulomatous reactions, frequently linked to systemic diseases.
- Primary hepatic lesions can also cause granulomatous hepatitis, complicating diagnosis.
Observation:
- A 21-year-old female presented with flu-like symptoms and jaundice, exhibiting cholestatic hepatocellular injury.
- Initial investigations excluded infections, tumors, and storage diseases as causes for the liver lesion.
Findings:
- Liver histology revealed granulomatous inflammation, intrahepatic bile duct proliferation, and micronodular cirrhosis.
- Clinical and laboratory findings, along with histology, suggested primary sclerosing cholangitis (PSC).
- The patient later developed pancolitis with terminal ileitis, supporting the PSC diagnosis.
Implications:
- Ursodeoxycholic acid treatment induced long-term remission in this patient with granulomatous hepatitis and PSC.
- This case underscores the diagnostic challenges and potential treatment responses in rare presentations of liver diseases.
- Early diagnosis and management of PSC, even with atypical hepatic manifestations, are crucial for patient outcomes.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...